CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Multiple Myeloma in Relapse · Multiple Myeloma, Refractory · Acute Lymphoblastic Leukemia, in Relapse · Acute Lymphocytic Leukaemia Refractory · Non-Hodgkin's Lymphoma, Relapsed · Non-Hodgkin's Lymphoma Refractory

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Hospital of Zhejiang Medical Colleage Zhejiang University, Hangzhou, Zhejiang, China
Contact: Study coordinator (He Huang, PhD) · hehuangyu@126.com · 86-13605714822

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

Multiple Myeloma

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · Phoenix, United States

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

Multiple Myeloma

Abroad (travel likely)RecruitingPHASE1

Coral Gables, United States · Deerfield Beach, United States

A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies

Multiple Myeloma · Hematologic Malignancies

Abroad (travel likely)RecruitingPHASE1

Chengdu, China

JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

Abroad (travel likely)RecruitingEARLY_PHASE1

Foshan, China